Previously, Kong et al. [21] have shown that LDN delayed motor dysfunction in transgenic male and female mice expressing familiar ALS-linked mutant superoxide dismutase (SOD1) and improved the phenotype of a pilocarpine model of epilepsy in male mice [21]. The gene discussed is SOD1; the disease is epilepsy.